Jan. 14, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system ...
Hosted on MSN1mon
Why Adaptive Biotechnologies Corporation (ADPT) Is Skyrocketing NowIn this article, we are going to take a look at where Adaptive Biotechnologies Corporation (NASDAQ:ADPT) stands against the other stocks that are skyrocketing now. The market has started to favor ...
Investors in Adaptive Biotechnologies Corp (Symbol: ADPT) saw new options become available this week, for the October 17th expiration. One of the key data points that goes into the price an option ...
ROBERT HERSHBERG, a director at $ADPT, sold 53,000 shares of the company on 03-12-2025 for an estimated $402,270. We received data on the trade from a recent SEC ...
Shares of NASDAQ ADPT opened at $7.84 on Monday. Adaptive Biotechnologies has a one year low of $2.28 and a one year high of $8.33. The firm has a market capitalization of $1.16 billion ...
Adaptive Biotechnologies (ADPT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates ...
Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Free Report)’s stock price fell 6.1% on Thursday after an insider sold shares in the company.The company traded as low as $7.46 and last traded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results